Organon will be a women's health company first and foremost even though the company will initially be made up of three very different types of businesses – women's health, established products and biosimilars. The cash generated from the substantially larger established products business will power the expansion of Organon into a global women's health leader, CEO Kevin Ali told Scrip.
"Established brands represents the business that will create oxygen for investing in inorganic opportunities for women's health," Ali said. "The driver today is making the most of the three businesses
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?